60 Degrees Pharmaceutical... (SXTP)
0.92
0.02 (2.11%)
At close: Jan 15, 2025, 2:19 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | 253.57K | 223.21K | 1.16M | 2.18M |
| Cost of Revenue | 474.55K | 432.37K | 850.74K | 702.99K |
| Gross Profit | -220.98K | -209.16K | 309.60K | 1.48M |
| Operating Income | -5.15M | -1.75M | -1.12M | -418.13K |
| Interest Income | n/a | n/a | n/a | n/a |
| Pretax Income | -3.81M | -6.18M | -4.26M | -3.05M |
| Net Income | -3.77M | -6.18M | -4.25M | -3.03M |
| Selling & General & Admin | 4.24M | 1.30M | 1.12M | 1.46M |
| Research & Development | 691.77K | 237.56K | 318.35K | 438.58K |
| Other Expenses | n/a | -43.24K | 37.52K | -121 |
| Operating Expenses | 4.93M | 1.54M | 1.43M | 1.85M |
| Interest Expense | 2.29M | 3.99M | 3.17M | 2.68M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
| Cost & Expenses | 5.41M | 1.97M | 2.28M | 2.55M |
| Income Tax | 250.00 | 500.00 | 1K | 1K |
| Shares Outstanding (Basic) | 3.96M | 5.78M | 5.78M | 5.78M |
| Shares Outstanding (Diluted) | 3.96M | 5.78M | 5.78M | 5.78M |
| EPS (Basic) | -0.95 | -1.07 | -0.74 | -0.52 |
| EPS (Diluted) | -0.95 | -1.07 | -0.74 | -0.52 |
| EBITDA | -1.43M | -2.11M | -1.01M | -341.17K |
| Depreciation & Amortization | 100.37K | 78.79K | 71.78K | 27.86K |